Seeking Alpha

A $2.2B settlement of a federal investigation into Johnson & Johnson (JNJ) sales practices...

A $2.2B settlement of a federal investigation into Johnson & Johnson (JNJ) sales practices is on hold, WSJ reports, as JNJ seeks to avoid wording in the agreement that could leave it vulnerable to private lawsuits. JNJ had agreed to settle a Justice Department investigation into allegations it had illegally promoted drugs including the antipsychotic Risperdal.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector